By Mill Chart
Last update: Feb 14, 2024
Our stock screener has spotted SANOFI-ADR (NASDAQ:SNY) as a good dividend stock with solid fundamentals. NASDAQ:SNY shows decent health and profitability. At the same time it gives a good and sustainable dividend. We'll dive into each aspect below.
To gauge a stock's dividend quality, ChartMill utilizes a Dividend Rating ranging from 0 to 10. This comprehensive assessment considers various dividend aspects, including yield, history, growth, and sustainability. NASDAQ:SNY has achieved a 8 out of 10:
ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:SNY, the assigned 5 for health provides valuable insights:
ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:SNY, the assigned 7 is noteworthy for profitability:
More Best Dividend stocks can be found in our Best Dividend screener.
Our latest full fundamental report of SNY contains the most current fundamental analsysis.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
52.39
+0.41 (+0.79%)
Find more stocks in the Stock Screener
SANOFI-ADR (SNY) offers strong profitability, an attractive dividend, and undervalued metrics, making it a compelling choice for value investors in the pharmaceutical sector.
SANOFI-ADR (SNY) offers a strong 4.27% dividend yield with sustainable payouts, solid profitability, and manageable debt, making it a top pick for income investors.